The Program shall:
(1)Be designed and maintained to provide security measures and processes required to safely distribute hypodermic needles and syringes and account for the number of hypodermic needles and syringes exchanged and distributed by the Baltimore City Health Department and the number of hypodermic needles and syringes in storage;
(2)Be operated to allow participants to exchange used hypodermic needles and syringes at available mobile syringe services sites;
(3)Include appropriate levels of staff expertise in working with injecting drug users and adequate staff training in providing community service provider referrals, counseling, and preventive education;
(4)Provide for the dissemination of other preventive means for decreasi
Free access — add to your briefcase to read the full text and ask questions with AI
The Program shall:
(1) Be designed and maintained to provide security measures and processes required to safely distribute hypodermic needles and syringes and account for the number of hypodermic needles and syringes exchanged and distributed by the Baltimore City Health Department and the number of hypodermic needles and syringes in storage;
(2) Be operated to allow participants to exchange used hypodermic needles and syringes at available mobile syringe services sites;
(3) Include appropriate levels of staff expertise in working with injecting drug users and adequate staff training in providing community service provider referrals, counseling, and preventive education;
(4) Provide for the dissemination of other preventive means for decreasing the risk of HIV transmission;
(5) Provide referrals to drug counseling and treatment services, and follow–up to those referrals to assure that participants receive the treatment they desire;
(6) Educate injecting drug users on the risk of transmitting HIV or the hepatitis B virus through high–risk needle–sharing practices and sexual behaviors;
(7) Include policies and procedures for the screening of applicants to the Program in order to preclude noninjecting drug users from participating in the Program; and
(8) Implement procedures for identifying Program participants that are consistent with the confidentiality provisions of this subtitle.